Location History:
- Verona, NJ (US) (1995 - 2003)
- Towaco, NJ (US) (2011 - 2015)
Company Filing History:
4 out of 4,945 
1 out of 1,217 
1 out of 1,650 
Years Active: 1995-2015
Title: **Innovator Spotlight: Jarema Peter Kochan**
Introduction
Jarema Peter Kochan is a notable inventor based in Verona, NJ, who has significantly contributed to the field of cancer diagnostics. With a portfolio of six patents, his work primarily focuses on innovative methods to aid in cancer assessment, showcasing his dedication to improving medical technologies and patient outcomes.
Latest Patents
Among his latest patents, one remarkable invention is the "Method for providing diagnosis of cancer using seprase as a marker." This invention introduces the human fibroblast activation protein (FAP/seprase) as a universal marker for various types of cancer, including lung and colon cancers. The method allows for the assessment of specific cancers from liquid samples, facilitating early detection and patient surveillance. Another significant patent is for the "Characterization and identification of unique human adiponectin isoforms and antibodies." This invention outlines methods for measuring different forms of human adiponectin in plasma and serum and provides unique antibodies that have potential applications in medical diagnostics.
Career Highlights
Jarema has had an impressive career, working at reputable organizations such as Hoffmann-La Roche Inc. and the United States Department of Health. His experience in these prestigious institutions has undoubtedly enriched his expertise and contributed to his inventive milestones in the health sector.
Collaborations
Throughout his career, Jarema has collaborated with distinguished professionals like Jean Pierre Kinet and Stephen Dalton. These collaborations have enhanced his research endeavors and facilitated the development of innovative solutions in cancer diagnosis.
Conclusion
Jarema Peter Kochan’s contributions to medical innovation, especially in cancer diagnostics, highlight his commitment to improving health outcomes through inventive solutions. His patents not only demonstrate his ingenuity but also reflect his collaborative spirit in pursuing advancements in healthcare technologies.